Antibiotic · Drug monograph
Pradofloxacin: veterinary dose and monograph
Pradofloxacin is a veterinary antibiotic. Third-generation veterinary fluoroquinolone (Veraflox) with enhanced activity against Gram-positives and anaerobes compared with earlier fluoroquinolones, plus a wide feline safety margin for the retina — making it a preferred… Indications include feline skin/soft-tissue infections and wounds/abscesses (Pasteurella, Staph); feline upper respiratory tract infection complications; canine pyoderma, UTI, soft-tissue and periodontal infections (where licensed). This monograph lists 5 reference doses for dogs, cats and birds, each with route, frequency and source.
At a glance
- Drug class
- Antibiotic
- Also known as
- Veraflox
- Species with doses
- Dogs, Cats and Birds
- General dose range
- 3–7.5 mg/kg PO q24h — check the species tables for the indication
- Routes
- PO
- Last reviewed
- 1 October 2026
Indications
- Feline skin/soft-tissue infections and wounds/abscesses (Pasteurella, Staph)
- Feline upper respiratory tract infection complications
- Canine pyoderma, UTI, soft-tissue and periodontal infections (where licensed)
- Susceptible Gram-negative and some anaerobic infections
Pradofloxacin dose by species
Doses are per administration unless stated. mg/kg doses scale with body weight; per-animal, per-quarter and infusion-rate doses are shown as the reference writes them.
Dogs
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Susceptible infection (where licensed) | 3–5 mg/kg | PO | q24h | — |
- Susceptible infection (where licensed): Papich 5e: 3–5 mg/kg q24h PO. Plumb’s 10e p.1050 (extra-label in the US): wounds, superficial and deep pyoderma, acute UTI and adjunct to periodontal therapy — 3–4.5 mg/kg PO once daily, the upper end often preferable; duration by response. Avoid in growing dogs (cartilage) and in dogs with seizure disorders.
Cats
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Skin / soft-tissue / wound infection | 5–7.5 mg/kg | PO | q24h | 7+ days |
| Bartonellosis | 5–10 mg/kg | PO | q12–24h (once daily preferred) | 28–42 days |
| Mycoplasma haemofelis | 5–10 mg/kg | PO | q24h | 14 days |
- Skin / soft-tissue / wound infection: Papich 5e: oral suspension 5–7.5 mg/kg q24h PO; tablets 3–5 mg/kg q24h. Plumb’s 10e p.1050 (label dosage; FDA-approved): skin infections (wounds, abscesses) 7.5 mg/kg PO once daily for 7 consecutive days; re-evaluate if no improvement in 3–4 days. Upper-respiratory infection (extra-label): suspension 5–7.5 mg/kg or tablets 3–4.5 mg/kg PO once daily, usually 5 days. Better feline retinal safety than enrofloxacin at label doses.
- Bartonellosis: Plumb’s 10e p.1050 (extra-label): 5–10 mg/kg PO once or twice daily for 28–42 days; larger once-daily doses are preferred. Often combined with a second class (e.g. doxycycline started 5–7 days earlier) — starting both together has caused a Jarisch-Herxheimer-like reaction.
- Mycoplasma haemofelis: Plumb’s 10e p.1050 (extra-label): 5–10 mg/kg PO once daily for 14 days.
Birds
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Staphylococcus / Streptococcus infections | 15 mg/kg | PO | q24h | — |
- Staphylococcus / Streptococcus infections: Plumb’s 10e p.1050 (extra-label): 15 mg/kg PO every 24 hours. Papich 5e gives no bird dose.
Contraindications
Growing dogs (arthropathy — and dose-dependent bone-marrow effects have limited canine tablet approval in some regions). Known fluoroquinolone hypersensitivity / history of fluoroquinolone-associated seizures. Use cautiously in epileptics. Pregnancy where alternatives exist.
Species-specific warnings
Cats: Preferred feline fluoroquinolone due to wide retinal safety margin — but still use susceptibility-guided to protect the class.
Dogs: Avoid in growing dogs (arthropathy) and respect dose limits (dose-dependent bone-marrow effects at high multiples).
Adverse effects
- GI upset (vomiting, soft stool)
- Cartilage effects in growing animals
- CNS excitation/seizures (rare, epileptics)
- Dose-dependent bone-marrow suppression in dogs at high multiples (basis of canine dosing limits)
Drug interactions
- Di-/tri-valent cations (antacids, sucralfate, dairy, iron/calcium): chelation reduces absorption — separate dosing
- Theophylline: reduced clearance, toxicity risk (less than older fluoroquinolones)
- NSAIDs: possible additive CNS excitation
- Drugs lowering seizure threshold: caution in epileptics
Pregnancy and lactation
Avoid in pregnancy where alternatives exist — fluoroquinolone arthropathy risk to the fetus.
Monitoring
- Culture & sensitivity (stewardship) and clinical response
- CBC in dogs on prolonged/high dosing
- CNS signs in epileptics
- Avoid in growing animals (joints)
Toxicity and overdose
Wide feline margin including for the retina (unlike enrofloxacin/ciprofloxacin which can blind cats). In dogs, dose-dependent bone-marrow effects at high multiples define the conservative canine dosing. Cartilage toxicity in juveniles is a class effect.
Management: No specific antidote. Decontaminate if recent large ingestion; supportive care, IV fluids; control seizures with benzodiazepines. Monitor CBC in dogs after significant overdose. Effects generally resolve with the drug's clearance.
Clinical pearls
- The fluoroquinolone of choice in CATS — broad activity with a wide retinal safety margin (unlike enrofloxacin/ciprofloxacin which can cause feline blindness)
- Once-daily dosing and good Gram-positive/anaerobe cover broaden its usefulness
- Dual-target action (gyrase + topoisomerase IV) may slow resistance — still reserve it via culture
- Separate from antacids/sucralfate/dairy by ≥2 h to preserve absorption
- Mind the species-specific canine dosing limits (bone-marrow effects at high multiples)
Mechanism of action
Inhibits bacterial DNA gyrase AND topoisomerase IV with relatively balanced dual targeting, blocking DNA replication — concentration-dependent bactericidal killing with a post-antibiotic effect. The dual high-affinity targeting broadens activity (including anaerobes and Gram-positives) and may slow stepwise resistance compared with single-target fluoroquinolones.
Formulations and products
- Oral suspension 25 mg/mL (2.5 %) — cats
- 15 / 60 / 120 mg flavoured tablet — dogs
- Veraflox (Elanco (Bayer)) — 25 mg/mL oral suspension (cats); 15/60/120 mg tablets (dogs), Oral suspension / tablet
Storage
Suspension: 15–30 °C, shake well, use within the labelled period after opening. Tablets: 15–30 °C, dry, protect from light.
Before you use this dose
Reference doses for veterinary professionals. Confirm the dose against the product label, the patient’s condition, current guidance and local regulations before use; the attending veterinarian remains responsible for every clinical decision.
Frequently asked questions
What is the dose of Pradofloxacin for dogs?
Reference doses for Pradofloxacin in dogs: 3–5 mg/kg PO q24h (Susceptible infection (where licensed)). Confirm against the label and the patient before use.
What is the dose of Pradofloxacin for cats?
Reference doses for Pradofloxacin in cats: 5–7.5 mg/kg PO q24h for 7+ days (Skin / soft-tissue / wound infection); 5–10 mg/kg PO q12–24h (once daily preferred) for 28–42 days (Bartonellosis); 5–10 mg/kg PO q24h for 14 days (Mycoplasma haemofelis). Confirm against the label and the patient before use.
What is the dose of Pradofloxacin for birds?
Reference doses for Pradofloxacin in birds: 15 mg/kg PO q24h (Staphylococcus / Streptococcus infections). Confirm against the label and the patient before use.
When should Pradofloxacin not be used?
Growing dogs (arthropathy — and dose-dependent bone-marrow effects have limited canine tablet approval in some regions). Known fluoroquinolone hypersensitivity / history of fluoroquinolone-associated seizures. Use cautiously in epileptics. Pregnancy where alternatives exist.
What are the side effects of Pradofloxacin in animals?
GI upset (vomiting, soft stool); Cartilage effects in growing animals; CNS excitation/seizures (rare, epileptics); Dose-dependent bone-marrow suppression in dogs at high multiples (basis of canine dosing limits).
Sources
- Plumb's Veterinary Drug Handbook
- Merck Veterinary Manual, 11th edition
- Papich, Papich Handbook of Veterinary Drugs, 5th edition
Last reviewed · VetMasterJi